Antibodies to human ErbB4
    17.
    发明授权
    Antibodies to human ErbB4 有权
    人ErbB4抗体

    公开(公告)号:US07332579B2

    公开(公告)日:2008-02-19

    申请号:US10362380

    申请日:2001-08-29

    摘要: The present invention concerns isolated antibodies that specifically bind to the human ErbB4 of SEQ ID NO:2, as well as humanized antibodies, human antibodies and antibody fragments, as well as bispecific antibodies capable of binding both the human ErbB4 of SEQ ID NO:2 and ErbB3. The invention further concerns antibodies which specifically bind to human ErbB4 of SEQ ID NO: 2 with a Kd less than 100 nM, antibodies which specifically bind to human ErbB4 of SEQ ID NO: 2 and which reduces heregulin binding thereto, and antibodies which specifically bind to human ErbB4 of SEQ ID NO: 2 and which reduce heregulin-induced tyrosine phosphorylation thereof.

    摘要翻译: 本发明涉及与SEQ ID NO:2的人ErbB4以及人源化抗体,人抗体和抗体片段特异性结合的分离的抗体,以及能够结合SEQ ID NO:2的人ErbB4两者的双特异性抗体 和ErbB3。 本发明还涉及以小于100nM的Kd特异性结合SEQ ID NO:2的人ErbB4的抗体,特异性结合SEQ ID NO:2的人ErbB4的抗体,并且其特异性结合的抗体 与SEQ ID NO:2的人ErbB4结合,并且其降低其胰腺素诱导的酪氨酸磷酸化。